StonvexLoading…
StonvexStonvexStonvexCore line items from ARMK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-03 | Q1 2026 2026-01-02 | Annual 2025 2025-10-03 | Q2 2025 2025-06-27 |
|---|---|---|---|---|
Revenue | $9.74B | $4.83B | $18.51B | $13.46B |
Operating Income | $437.30M | $217.55M | $791.85M | $574.03M |
Net Income | $198.11M | $96.16M | $326.39M | $239.26M |
EPS (Diluted) | $0.74 | $0.36 | $1.22 | $0.90 |
Total Assets | $13.84B | $13.54B | $13.30B | $13.28B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $475.72M | $439.63M | $639.10M | $501.49M |
Free Cash Flow OCF − CapEx | $-605.38M | $-904.36M | $431.80M | $-601.57M |
Shares Outstanding | 262.80M | 262.82M | 262.90M | 262.64M |